Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCLS Holdings Regulatory News (CLI)

Share Price Information for CLS Holdings (CLI)

Share Price is delayed by 15 minutes
Get Live Data
47.15    -1.40 (-2.88%)
Bid:
46.70
Ask:
48.60
Spread: 1.90 (4.069%)
Market Cap: £187.71m
CLI Live PriceLast checked at - London Stock Exchange

Intraday CLS Holdings Share Chart

Director/PDMR Shareholding

28 Apr 2016 15:01

RNS Number : 7099W
CLS Holdings PLC
28 April 2016
 

 

 

 

 

 

 

TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARESi

 

 

1. Identity of the issuer or the underlying issuerof existing shares to which voting rights areattached: ii

CLS Holdings plc

2 Reason for the notification (please tick the appropriate box or boxes):

An acquisition or disposal of voting rights

X

An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached

 

An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments

 

An event changing the breakdown of voting rights

 

Other (please specify):

 

 

3. Full name of person(s) subject to thenotification obligation: iii

Creative Value Investment Group Limited ("CVIG")

4. Full name of shareholder(s) (if different from 3.):iv

Creative Value Investment I Limited

Creative Value Investment II Limited

Creative Value Investment III Limited

(together, the "CVIs")

 

5. Date of the transaction and date onwhich the threshold is crossed orreached: v

28 April 2016

6. Date on which issuer notified:

28 April 2016

7. Threshold(s) that is/are crossed orreached: vi, vii

Above 50%

      
 

 

8. Notified details:

A: Voting rights attached to shares viii, ix

Class/type ofshares

if possible usingthe ISIN CODE

Situation previousto the triggeringtransaction

Resulting situation after the triggering transaction

NumberofShares

NumberofVotingRights

Numberof shares

Number of votingrights

% of voting rights x

Direct

Direct xi

Indirect xii

Direct

Indirect

 

 

GB0001592475

Nil

Nil

Nil

 

21,369,429

 

50.70%

 

 

B: Qualifying Financial Instruments

Resulting situation after the triggering transaction

Type of financialinstrument

Expirationdate xiii

Exercise/Conversion Period xiv

Number of votingrights that may beacquired if theinstrument isexercised/ converted.

% of votingrights

 

 

 

 

 

 

C: Financial Instruments with similar economic effect to Qualifying Financial Instruments xv, xvi

Resulting situation after the triggering transaction

Type of financialinstrument

Exercise price

Expiration date xvii

Exercise/Conversion period xviii

Number of voting rights instrument refers to

 

% of voting rights xix, xx

 

 

 

 

 

 

 

Nominal

Delta

 

 

 

Total (A+B+C)

Number of voting rights

Percentage of voting rights

21,369,429

50.70%

                 
 

 

9. Chain of controlled undertakings through which the voting rights and/or thefinancial instruments are effectively held, if applicable: xxi

 

The following undertakings, which immediately following the transaction were each directly held and beneficially owned by CVIG, directly hold the following number of shares in the issuer:

 

Creative Value Investment I Limited: 8,153,810 (19.34%)

Creative Value Investment II Limited: 6,094,828 (14.46%)

Creative Value Investment III Limited: 7,120,791 (16.89%)

 

Total: 50.70%

 

Proxy Voting:

10. Name of the proxy holder:

 

11. Number of voting rights proxy holder will ceaseto hold:

 

12. Date on which proxy holder will cease to holdvoting rights:

 

 

13. Additional information:

Sten Mortstedt has transferred all of his shareholdings in the CVIs to CVIG in consideration for the issue of shares in CVIG to Sten Mortstedt. Immediately following that transaction, Sten Mortstedt settled his entire shareholding in CVIG into The Sten and Karin Mortstedt Family & Charity Trust. The beneficial interest of Sten Mortstedt in the issuer remains unchanged as a result of these transactions.

 

14. Contact name:

Peter Zonabend

15. Contact telephone number:

+41 81 252 55 47

   

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
DSHAKFDKQBKDKQB
Date   Source Headline
21st Nov 202311:13 amRNSDirector Declaration
15th Nov 20237:00 amRNSQ3 Trading Update
20th Oct 20235:20 pmRNSDirector/PDMR Shareholding
25th Sep 20239:16 amPRNDirector Declaration
25th Sep 20237:00 amRNSDirectorate Change
12th Sep 20235:33 pmRNSDirector/PDMR Shareholding
12th Sep 20234:17 pmRNSDirector/PDMR Shareholding
4th Sep 20234:41 pmRNSDirector/PDMR Shareholding
4th Sep 20234:38 pmRNSTR-1 Notification of Major Holdings
23rd Aug 20234:05 pmRNSDirector/PDMR Shareholding
18th Aug 20233:59 pmRNSDirector/PDMR Shareholding
18th Aug 20233:55 pmRNSNotification of Major Shareholdings
11th Aug 20234:50 pmRNSDirector/PDMR Shareholding
1st Aug 202311:17 amRNSNotice of Results
7th Jul 20235:28 pmRNSDirector/PDMR Shareholding
3rd Jul 20232:20 pmRNSDirector/PDMR Shareholding
30th Jun 20237:00 amRNSCLS announces 30-year lease in Essen, Germany
27th Jun 20237:00 amRNSCLS announces the sale of three properties
23rd Jun 20233:15 pmRNSDirector/PDMR Shareholding
15th Jun 20235:51 pmRNSDirector/PDMR Shareholding
15th Jun 20235:49 pmRNSNotification of Major Shareholding
15th Jun 20235:44 pmRNSDirector/PDMR Shareholding
8th Jun 20232:14 pmRNSDirector/PDMR Shareholding
5th Jun 20234:51 pmRNSDirector/PDMR Shareholding
30th May 20232:55 pmRNSDirector/PDMR Shareholding
30th May 20232:52 pmRNSHolding(s) in Company
26th May 20234:39 pmRNSTotal Voting Rights
18th May 20237:02 amRNSDirector/PDMR Shareholding
18th May 20237:00 amRNSHolding(s) in Company
12th May 20234:40 pmRNSDirector/PDMR Shareholding
11th May 20235:15 pmRNSDirector/PDMR Shareholding
27th Apr 20234:32 pmRNSResult of AGM
17th Apr 20231:57 pmRNSDirector/PDMR Shareholding
13th Apr 20233:51 pmRNSDirector/PDMR Shareholding
24th Mar 20237:22 amRNSNotice of Results
24th Mar 20237:17 amRNSDirector/PDMR Shareholding
15th Mar 20234:29 pmRNSDirector/PDMR Shareholding
15th Mar 20231:17 pmRNSDirector/PDMR Shareholding
10th Mar 20234:31 pmRNSDirector/PDMR Shareholding
8th Mar 20237:00 amRNSAnnual Financial Report
10th Feb 20235:02 pmRNSDirector/PDMR Shareholding
23rd Jan 20237:00 amRNSNotice of Full Year Results
17th Jan 20235:17 pmRNSDirector/PDMR Shareholding
20th Dec 20225:45 pmRNSDirector/PDMR Shareholding
29th Nov 202211:18 amRNSDirector/PDMR Shareholding
16th Nov 20227:00 amRNSQ3 Trading Update
8th Nov 20227:00 amRNSCLS Secures Three New Leases in Germany
18th Oct 20223:14 pmRNSDirector/PDMR Shareholding
13th Oct 20227:00 amRNSDisposal
12th Oct 20223:28 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.